|Genomics & Big Data Summit|
Metabolomics - Advances & Applications in Human Disease
Next Generation Sequencing
Big Data Bioinformatics
CRISPR & Genome Engineering
GTCbio is proud to present the Metabolomics – Advances & Applications in Human Disease Conference, which is part of The Genomics & Big Data Summit and takes place September 26-27, 2017 in San Diego, CA.
There is still significant human variability in metabolite identification for targets and pathways. These challenges affect the advancement in biomarker development, mass spectrometry-cased imaging, big data, and the application of metabolomics for drug discovery and development. Join us for an event that presents new research and offers networking opportunities with the researchers and scientists who are working on developing clinical assays, connecting the metabolome and the genome, and establishing common quality standards for experimental data.
Joint Plenary Sessions:
- Opening Keynote Session – Historical Perspective & Current State of the Industry
- Round Table Discussions
- Lunch Session – Ethical Challenges of Big Data and Genomics Application
- Award Ceremony & Closing Keynote Session – Predictions for the Future
- Advances in Metabolite Discovery and Validation
- Translating Metabolomics Discoveries to Clinical Practice
We hope to see you there!
The 2017 Advisory Committee
Amber Kempf at 626-256-6405 or amber.kempf [at] gtcbio.com
Cancer Genetics Inc. (CGI; Nasdaq: CGIX) is a leader in enabling precision medicine in oncology from bench to bedside through the use of oncology biomarkers and molecular testing. CGI is developing a global footprint with locations in the US, India and China. The Company offers a comprehensive range of laboratory services that provide critical genomic and biomarker information. Its state-of-the-art reference labs are CLIA-certified and CAP-accredited in the US and have licensure from several states including New York State. CGI has established strong clinical research collaborations with major cancer centers such as Memorial Sloan Kettering, The Cleveland Clinic, Mayo Clinic, Keck School of Medicine at USC and the National Cancer Institute.